Search results

From Self-sufficiency
Jump to: navigation, search
  • ...a [[local anaesthetic]] drug belonging to the [[amino]] [[amide]] group. [[AstraZeneca]] commonly markets it under various [[trade name]]s, including '''Marcain''
    6 KB (809 words) - 14:05, 6 July 2010
  • | bioavailability= 35–76%<ref>http://www1.astrazeneca-us.com/pi/Prilosec.pdf</ref><ref>http://www.medscape.com/viewarticle/508018 ...ble from [[Generic drug|generic]] manufacturers under various brand names. AstraZeneca markets omeprazole as '''Losec''', '''Antra''', '''Gastroloc''', '''Mopral'
    17 KB (2,299 words) - 08:15, 5 September 2010
  • [[Category:AstraZeneca]]
    12 KB (1,720 words) - 15:48, 27 September 2010
  • ...]] and is marketed worldwide as '''Prinivil''' or '''Tensopril''' and by [[AstraZeneca]] as '''Zestril'''. In India it is marketed by [[Micro Labs]] as '''Hipril' *[http://www1.astrazeneca-us.com/pi/zestrillpv.pdf Prescribing information for ZESTRIL]
    10 KB (1,316 words) - 08:44, 20 September 2010
  • ...[[International Nonproprietary Name|INN]], marketed as '''Diprivan''' by [[AstraZeneca]]) is a short-acting, [[intravenous therapy|intravenously]] administered [[ ...in water. The emulsified formulation was relaunched in 1986 by ICI (now [[AstraZeneca]]) under the brand name '''Diprivan''' (abbreviated version of '''di'''iso'
    21 KB (2,875 words) - 20:03, 24 September 2010